Leonteq Securities’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
CF
MBAM
Leonteq Securities's HCAT Position: Q3 2026 in Review
Leonteq Securities held its Health Catalyst (HCAT) position steady in Q3 2026 at 23 shares worth $40. The position accounts for ﹤0.01% of the portfolio, ranked #1275.
Leonteq Securities first reported a position in HCAT in Q2 2022 and has held it in 17 quarters since. The position peaked at $9.9K in Q1 2023. 109 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.
- Leonteq Securities held 23 shares of Health Catalyst worth $40 as of Q3 2026.
- Leonteq Securities left its Health Catalyst share count unchanged in Q3 2026.
- Health Catalyst made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #1275 holding.
- Leonteq Securities first reported a position in Health Catalyst in Q2 2022 and has held it in 17 quarters since.
- Leonteq Securities's Health Catalyst position peaked at $9.9K in Q1 2023.
- 109 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.